Journal of Commercial Biotechnology

Current Issue

Vol 24 No 4 (2019)
Published September 7, 2019

Articles

Arthur A. Boni
Transforming Technology Into High-Value Solutions for Compelling Biomedical Needs: Bio Entrepreneurship Bootcamp 2.0
https://doi.org/10.5912/jcb908
Requires Subscription or Fee PDF
Arthur A. Boni
Evolution of the Screening Metaphor: Project, Product, or Platform?
https://doi.org/10.5912/jcb909
Requires Subscription or Fee PDF
Arthur A. Boni, Diana Joseph
Aligning the Corporation for Transformative Innovation: Introducing Innovation Dashboard 2.0
https://doi.org/10.5912/jcb910
Requires Subscription or Fee PDF
Arthur A. Boni, Diana Joseph
Four Models for Corporate Transformative, Open Innovation
https://doi.org/10.5912/jcb911
Requires Subscription or Fee PDF
Kathryn Doyle
IP Fundamentals – What Every CEO Should Know About IP in Biotechnology
https://doi.org/10.5912/jcb912
Requires Subscription or Fee PDF
Raymond A. Miller
Intellectual Property for Life Science Entrepreneurs
https://doi.org/10.5912/jcb913
Requires Subscription or Fee PDF
James Jordan
Intellectual Property – Solidify Your Competitive Edge
https://doi.org/10.5912/jcb914
Requires Subscription or Fee PDF
Edwin Gordon
2018 Mostly a Sideways Market Masking a Lot of Excitement: Innovation and Science Keep the Party Rolling
https://doi.org/10.5912/jcb915
Requires Subscription or Fee PDF
James Jordan, David Smith
Founding and Funding a Life Sciences Company: An Overview
https://doi.org/10.5912/jcb916
Requires Subscription or Fee PDF
Claudine Kearney
Strategic Planning for Financing and Growing Biotechnology Companies: Strategic Planning for Financing and Growing Biotechnology Companies
https://doi.org/10.5912/jcb917
Requires Subscription or Fee PDF
Arthur A. Boni, Stephen Sammut
“The Good, the Bad, the Ugly”: Leadership Lessons From two Companies – Amgen and Theranos
https://doi.org/10.5912/jcb918
Requires Subscription or Fee PDF
Arthur A. Boni
Leading and Managing Teams in Entrepreneurial Organizations: an Experiential Perspective
https://doi.org/10.5912/jcb919
Requires Subscription or Fee PDF
Gergana Todorova
Building and Managing Great Teams: An Evidence-Based Approach
https://doi.org/10.5912/jcb920
Requires Subscription or Fee PDF
James Jordan
Setting Up and Working with a Board of Directors: A Guide for Startups
https://doi.org/10.5912/jcb921
Requires Subscription or Fee PDF
Moira Gunn
When an FDA Drug Approval Makes Mainstream News: The Announcement of Zulresso, A Media Case Study
https://doi.org/10.5912/jcb922
Requires Subscription or Fee PDF
Erwin A. Blackstone, Joseph P. Fuhr Jr.
The Complexity of Pharmaceutical Prices: An Economic Analysis
https://doi.org/10.5912/jcb923
Requires Subscription or Fee PDF
Thani Jambulingam
The R&D Marketing Interface in Biopharma and MedTech
https://doi.org/10.5912/jcb924
Requires Subscription or Fee PDF
View All Issues